When to Hold Sliding Scale Insulin
You should reassess the insulin regimen when blood glucose falls below 100 mg/dL (5.6 mmol/L), and modification is required when blood glucose is below 70 mg/dL (3.9 mmol/L). 1, 2
Critical Thresholds for Action
Reassessment Zone: BG < 100 mg/dL (5.6 mmol/L)
- Consider reducing or holding insulin doses at this level to prevent progression to hypoglycemia
- This is your warning zone—don't wait for frank hypoglycemia to develop 1
Mandatory Modification: BG < 70 mg/dL (3.9 mmol/L)
- Modification of the insulin regimen is required at this threshold
- This is the standard definition of hypoglycemia and correlates with the initial release of counterregulatory hormones 1
- The only exception is if the low glucose is easily explained by other factors (such as a missed meal) 1
Important Context About Sliding Scale Insulin
Sliding scale insulin (SSI) as monotherapy is strongly discouraged and should not be the sole method of insulin treatment in hospitalized patients. 1, 3 The guidelines are remarkably consistent on this point across multiple years. SSI is a reactive approach that treats hyperglycemia after it occurs rather than preventing it, leading to rapid glucose fluctuations and both hyper- and hypoglycemia 4.
Why This Matters for Your Question
If you're asking about holding SSI specifically:
- SSI should ideally be replaced with a basal-bolus or basal-plus regimen 1, 5, 3
- If SSI must be used temporarily (e.g., in patients with mild hyperglycemia, good baseline control with HbA1c <7%, or those NPO with no nutritional replacement), the same thresholds apply 6
Practical Algorithm
For any insulin regimen (including SSI):
- BG ≥ 100 mg/dL: Proceed with scheduled insulin as ordered
- BG 70-99 mg/dL: Hold or reduce insulin dose; reassess regimen
- BG < 70 mg/dL: Hold insulin and modify regimen (unless clearly explained by missed meal)
- BG < 54 mg/dL: This represents severe hypoglycemia requiring immediate treatment 6
Common Pitfalls to Avoid
- Don't wait for symptomatic hypoglycemia: Early recognition and treatment of mild to moderate hypoglycemia (40-69 mg/dL) prevents deterioration to severe episodes with adverse sequelae 1
- Don't continue SSI unchanged throughout hospitalization: This is a major problem with SSI regimens—they're prescribed on admission and continued without modification even when control remains poor 4
- Don't ignore the 100 mg/dL threshold: This is your opportunity to prevent hypoglycemia before it occurs, which is associated with higher mortality 3
The evidence consistently shows that basal-bolus insulin achieves better glycemic control (68% vs 38% achieving mean BG <140 mg/dL) with no increase in hypoglycemia compared to SSI alone 4.